Portable defibrillator

Heart attacks were killing people in the corridor between home and hospital. By the early 1960s doctors already knew that ventricular fibrillation could often be reversed with an external DC defibrillator, but the machine lived inside coronary wards. It was heavy, mains-powered, and chained to the building. Frank Pantridge looked at that arrangement in Belfast and saw the real bottleneck: many patients were dying before they ever reached the room where the machine stood.

Pantridge's conclusion came from local conditions as much as from invention. Working at the Royal Victoria Hospital in Belfast, he and cardiologist John Geddes were treating large numbers of myocardial infarction cases in a compact city where ambulance travel times were short enough to matter. Belfast therefore became a test bed for a new idea: move coronary care outward instead of waiting for the patient to arrive. The portable defibrillator was the instrument that made that reorganization credible.

Its prerequisites were already on the table. The external DC defibrillator had shown that a controlled capacitor discharge was safer than older alternating-current shocks. The electrocardiography machine had taught clinicians how to recognize lethal rhythms quickly enough to act. Battery power, transistor electronics, and lighter capacitors had advanced far enough that defibrillation no longer had to mean a wall socket and a rolling cart. None of those ingredients alone was enough. Together they opened the adjacent possible.

The first Belfast unit, deployed in 1965, was still a brute. It weighed about 70 kilograms and drew power from two car batteries. Yet even that ungainly prototype changed the geometry of emergency medicine. Instead of treating defibrillation as a hospital procedure, Pantridge and Geddes treated it as something that could ride in a vehicle, arrive at a curbside, and intervene in the minutes when rhythm loss is most often fatal. A 1967 report in *The Lancet* gave the idea wider visibility, and the same team soon pushed the machine through another crucial shrink. By 1968, a miniature capacitor first developed for the US space program helped reduce the device to roughly 3 kilograms, making genuine field portability possible.

That sequence is path dependence in hardware form. Pantridge did not invent defibrillation from scratch. He inherited Beck, Zoll, Gurvich, and Lown's earlier work and changed the location of use. But changing the location changed the whole system. Once doctors could imagine defibrillation happening in ambulances rather than only in wards, ambulance design, dispatch practice, paramedic training, and coronary-care protocols all began to move around that capability.

That is also niche construction. The portable defibrillator altered the environment into which later cardiac devices were born. Mobile coronary care units spread from Belfast to cities in Europe and North America. Emergency medical services stopped being transport alone and became treatment platforms. Hospitals built receiving pathways around prehospital rhythm care. The machine did not merely save individual patients; it reorganized the institutions that met them.

An adaptive radiation followed. One branch stayed with professionals and led to lighter ambulance defibrillators and monitoring systems. Another branch moved toward automation, producing the automated external defibrillator that could guide less-specialized rescuers through rhythm analysis and shock delivery. A third branch moved inside the body, helping normalize the logic behind the implantable cardioverter-defibrillator. All three branches depended on the same first break with the hospital wall: defibrillation could be portable, not just powerful.

Commercial scale came later than conceptual proof. Belfast's prototypes were essentially clinical machines built to solve an urgent local problem, and many later products were commercial descendants rather than original inventions. What mattered first was demonstration. Once Pantridge showed that early defibrillation in the field was technically possible and medically worthwhile, manufacturers had a design target and health systems had a reason to buy.

Portable defibrillators matter because they changed where the clock starts. Sudden cardiac death is ruthless about minutes. By lifting defibrillation out of the fixed coronary ward, Pantridge's team turned geography into something medicine could fight rather than merely endure. After that, every airport AED and every shock-ready ambulance was working inside the niche Belfast had built.